Expression of three receptors—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2)—are routinely used to determine optimal treatment plans for breast cancer patients [4]. This evidence concerns the gene ESR1 and breast cancer.